Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S734

Introduced
2/27/25  

Caption

Ensuring access to specialty medications

Impact

This bill is poised to have significant implications on state laws governing pharmacies and the dispensing of medications. By requiring pharmacies to adhere to stringent licensing procedures, the bill seeks to improve oversight and accountability in the handling of specialty medications, which often require special storage or handling due to their high cost or complex administration. This aligns with efforts to promote patient safety and ensure that patients have access to necessary medications without unnecessary barriers.

Summary

Bill S734, titled 'An Act Ensuring Access to Specialty Medications', aims to strengthen access to specialty medications for patients within Massachusetts. The legislation introduces a new section in Chapter 112 of the General Laws, defining 'specialty pharmacies' and establishing licensing procedures for these entities. The provisions ensure that all pharmacies dispensing specialty medications, except for mail service pharmacies, comply with specific regulations that aim to safeguard public health and enhance medication accessibility.

Contention

Notable points of contention surrounding S734 may arise from differing opinions on the impact of increased regulation on pharmacy operations. Proponents argue that enhanced oversight will lead to better health outcomes by ensuring that specialty medications are handled appropriately. However, critics may contend that additional regulations could place a burden on smaller pharmacies, potentially leading to disparities in access for patients dependent on these medications. Additionally, there may be discussions on insurance guidelines regarding the dispensing of specialty medications, as specified in amendments to Chapter 176D, which could spark debates about healthcare costs and access.

Companion Bills

No companion bills found.

Similar Bills

MA S665

Relative to specialty medications and patient safety

MA H1144

Relative to specialty medications and patient safety

MA S777

Relative to specialty medications and patient safety

LA SCR87

Requests the Louisiana Board of Pharmacy to study and make recommendations regarding the use of the terms "specialty drug" and "specialty pharmacy".

CA AB910

Pharmacy benefit management.

MD HB876

Health Insurance - Pharmacy Benefits Managers - Specialty Drugs

CA AB2348

Pharmacy benefit management.

MA H1322

Ensuring access to specialty medications